Most previous studies investigating the association between MetS and SMM by dual DEXA [10,11,12] or BIA [13,14] revealed that an increased SMM reduces the risk of MetS, thus highlighting the positive effects of skeletal muscle on insulin control. The gene discussed is INS; the disease is metabolic syndrome.